Cardiovascular disease prevention
KEYWORDS: evidence, health, cvd, food, statement, programmes, study, evidence statement, risk, studies, community, cba, population, prevention, disease

R3.E3c, R4.4a, R4.9e, R4.18a, R4.18b, R4.25e; additional evidence ER 3, ER 9, ER 10 Recommendation 21: evidence statements R4.1b, R4.3a, R4.3b, R4.7a窶田, R4.8a窶電, R4.16a窶田, R4.17a窶電, R5.3, R5.7, R5.8, R5.9, R5.11, R5.12; additional evidence ER 5, ER 7, ER 8 Recommendation 22: evidence statements R4.3a, R4.18a, R4.18c, R5.10; additional evidence ER 1, ER 5, ER 7, ER 8, ER 12, IDE Recommendation 23: evidence statements R3.E3a, R3.E3c, R4.18a, R4.18b; additional evidence ER 3, ER 4, ER 9, ER 10 Recommendation 24: evidence statements R4.9e; additional evidence ER 3, ER 9, ER 10 In addition, the approach taken in recommendations 1 to 12 is supported by the following evidence statements: R4.3a, R4.3b, R4.4a, R4.18a, R418b, R418c, R5.9 and additional evidence ER10, ER11, ER12, ER13. Evidence statements Please note that the wording of some evidence statements has been altered slightly from those in the evidence reviews to make them more consistent with each other and NICE's standard house style. Evidence statement R3.E1a CVD mortality and morbidity: Limited evidence from 3 out of 38 programme evaluations using different summary effect measures demonstrate a mixed effect of multiple risk factor interventions (MRFI) on CVD mortality (the majority of programmes were beneficial) with two controlled before-and-after
